Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience - Concepedia

Concepedia

Publication | Open Access

Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience

DOI Full Paper Access

10

Citations

21

References

2015

Year

Yasir Bashir, Sajjad Geelani, Nusrat Bashir, S Mir, Mosin Mushtaq, Mohammed A Jan, Javid Rasool

South Asian Journal of Cancer

Abstract

Low dose cytarabine is effective treatment option for elderly patients with AML when standard treatment options are not warranted.

References

	Year	Citations
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia Bruce D. Cheson, John M. Bennett, Thomas Büchner, Journal of Clinical Oncology Mixed-phenotype Acute LeukemiaPathologyAcute LeukemiaResponse CriteriaHematological Malignancy	2003	2.6K
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry Gunnar Juliusson, Petar Antunović, Åsa Rangert Derolf, Blood	2008	983
Anthracycline Dose Intensification in Acute Myeloid Leukemia Hugo F. Fernández, Zhuoxin Sun, Xiaopan Yao, New England Journal of Medicine	2009	900
A comparison of low‐dose cytarabine and hydroxyurea with or without all‐trans retinoic acid for acute myeloid leukemia and high‐risk myelodysplastic syndrome in patients not considered fit for intensive treatment Alan K. Burnett, Donald Milligan, Archie Prentice, Cancer	2007	613
Cytarabine Dose for Acute Myeloid Leukemia Bob Löwenberg, Thomas Pabst, Edo Vellenga, New England Journal of Medicine	2011	405
Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Yates Jw, Wallace Hj, Ellison Rr, PubMed Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematology	1974	368
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients Mikkael A. Sekeres, Paul Elson, Matt Kalaycio, Blood	2008	216
Different Blocks in the Differentiation of Myeloid Leukemic Cells Joseph Lotem, Leo Sachs Proceedings of the National Academy of Sciences	1974	191
Small doses of ARA‐C in the treatment of acute myeloid leukaemia: differentiation of myeloid leukaemia cells? M. Housset, Marie‐Thérèse Daniel, L Degos British Journal of Haematology	1982	189
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 Trial R. Willemze, Stefan Suciu, Giovanna Meloni, Journal of Clinical Oncology	2013	165

Page 1